OnKure Therapeutics, Inc.
OKUR
$4.25
-$0.15-3.41%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -58.75M | -59.52M | -63.46M | -60.31M | -59.06M |
| Total Depreciation and Amortization | 821.00K | 830.00K | 836.00K | 787.00K | 723.00K |
| Total Amortization of Deferred Charges | -- | -- | 14.00K | 141.00K | 142.00K |
| Total Other Non-Cash Items | 11.67M | 11.64M | 11.32M | 8.44M | 7.34M |
| Change in Net Operating Assets | -4.51M | -4.78M | -12.39M | -10.35M | -3.64M |
| Cash from Operations | -50.76M | -51.83M | -63.67M | -61.29M | -54.49M |
| Capital Expenditure | -33.00K | -46.00K | -52.00K | -64.00K | -61.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 15.93M | 15.93M | 15.93M |
| Cash from Investing | -33.00K | -46.00K | 15.87M | 15.86M | 15.86M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 6.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 146.24M | 240.00K | 58.88M | 58.89M | 58.90M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -77.00K | 51.29M | 51.29M | 51.15M |
| Cash from Financing | 146.24M | 163.00K | 110.17M | 110.17M | 116.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 95.45M | -51.71M | 62.37M | 64.74M | 77.41M |